Peer Review reports
From: Changes in initiation of adjuvant endocrine therapy for breast cancer after state health reform
| Original Submission | ||
|---|---|---|
| 12 Jan 2021 | Submitted | Original manuscript |
| 3 Feb 2021 | Reviewed | Reviewer Report |
| 7 Feb 2021 | Reviewed | Reviewer Report |
| 3 Mar 2021 | Author responded | Author comments - Kirsten Eom |
| Resubmission - Version 2 | ||
| 3 Mar 2021 | Submitted | Manuscript version 2 |
| 10 Mar 2021 | Author responded | Author comments - Kirsten Eom |
| Resubmission - Version 3 | ||
| 10 Mar 2021 | Submitted | Manuscript version 3 |
| 16 Mar 2021 | Author responded | Author comments - Kirsten Eom |
| Resubmission - Version 4 | ||
| 16 Mar 2021 | Submitted | Manuscript version 4 |
| 23 Mar 2021 | Reviewed | Reviewer Report |
| Resubmission - Version 5 | ||
| Submitted | Manuscript version 5 | |
| Publishing | ||
| 30 Mar 2021 | Editorially accepted | |
| 1 May 2021 | Article published | 10.1186/s12885-021-08149-0 |
You can find further information about peer review here.